“…However, considerable progress has been made in the molecular characterization of Cryptosporidium since the development of these tests, resulting in the identification of at least seven human-infecting species (3,18). Cryptosporidium parvum and C. hominis remain the two most frequent species detected with various levels of prevalence in different countries (2,6,7,12,15,17) but with a high (up to 90%) predominance of C. hominis in tropical and developing countries (1,4,5,18). Species other than C. parvum and C. hominis have also emerged as causes of cryptosporidiosis in both immunocompromised and immunocompetent patients (2,4,5).…”